$18.19
-0.42-2.26%
Last update: Oct 30, 4:00 PM
Arcus Biosciences Inc
RCUSNYSE
Arcus Biosciences (RCUS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.85 | $-0.85 | $-1.09 | $-1.31 |
| Actual | $-0.72 | $-1.02 | $-0.89 | $-1.27 |
| Surprise | +15.3% | -20.0% | +18.4% | +3.05% |
| Revenue | ||||
| Estimate | $21.6M | $26.4M | $25.0M | $20.3M |
| Actual | $41.0M | $17.0M | $33.0M | $26.0M |
| Surprise | +89.9% | -35.6% | +32.2% | +27.9% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.90 | $-0.85 | $-0.84 | $-0.80 |
| Revenue | ||||
| Consensus | $9.0M | $6.7M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.72 | $-0.85 | 15.3 % |
| Q1 | May 5, 2026 | $-1.02 | $-0.85 | -20.0 % |
| Q4 | Feb 25, 2026 | $-0.89 | $-1.09 | 18.4 % |
| Q3 | Oct 28, 2025 | $-1.27 | $-1.31 | 3.05 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $41.00M | $21.59M | 89.9 % |
| Q1 | May 5, 2026 | $17.00M | $26.39M | -35.6 % |
| Q4 | Feb 25, 2026 | $33.00M | $24.96M | 32.2 % |
| Q3 | Oct 28, 2025 | $26.00M | $20.33M | 27.9 % |
